June‐Yong Lee

4.6k total citations · 3 hit papers
56 papers, 3.4k citations indexed

About

June‐Yong Lee is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, June‐Yong Lee has authored 56 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 16 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in June‐Yong Lee's work include Immune Cell Function and Interaction (11 papers), T-cell and B-cell Immunology (11 papers) and Endometrial and Cervical Cancer Treatments (6 papers). June‐Yong Lee is often cited by papers focused on Immune Cell Function and Interaction (11 papers), T-cell and B-cell Immunology (11 papers) and Endometrial and Cervical Cancer Treatments (6 papers). June‐Yong Lee collaborates with scholars based in United States, South Korea and Italy. June‐Yong Lee's co-authors include Stephen C. Jameson, Kristin A. Hogquist, Cara Skon-Hegg, Kristin G. Anderson, David Masopust, Dan R. Littman, Adovi Akue, Jason A. Hall, Jae U. Jung and Chengyu Liang and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

June‐Yong Lee

51 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Transcriptional downregulation of S1pr1 is required for the establishment of resident memory CD8+ T cells

2013 611 citations Cara Skon-Hegg, June‐Yong Lee et al. Nature Immunology profile →
An IL-23R/IL-22 Circuit Regulates Epithelial Serum Amyloid A to Promote Local Effector Th17 Responses

2015 440 citations June‐Yong Lee, Emily R. Miraldi et al. profile →
Serum Amyloid A Proteins Induce Pathogenic Th17 Cells and Promote Inflammatory Disease

2019 335 citations June‐Yong Lee, Dan R. Littman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
June‐Yong Lee United States	23	1.7k	1.2k	660	589	268	56	3.4k
Niklas Beyersdorf Germany	28	1.4k 0.9×	1.2k 1.0×	569 0.9×	388 0.7×	212 0.8×	80	3.4k
Jonathan P. Moorman United States	38	1.6k 1.0×	1.2k 1.0×	928 1.4×	525 0.9×	464 1.7×	128	3.7k
Lynn Williams United Kingdom	27	1.7k 1.0×	1.1k 0.9×	375 0.6×	705 1.2×	145 0.5×	40	3.4k
Wumesh KC United States	13	2.2k 1.3×	1.0k 0.9×	719 1.1×	306 0.5×	196 0.7×	16	3.4k
Laura M. Sly Canada	36	1.8k 1.1×	1.4k 1.1×	426 0.6×	424 0.7×	416 1.6×	63	3.5k
Kevin Shenderov United States	13	2.4k 1.5×	1.4k 1.1×	1.1k 1.6×	427 0.7×	426 1.6×	17	4.2k
Laurien H. Ulfman Netherlands	28	1.2k 0.8×	878 0.7×	406 0.6×	371 0.6×	286 1.1×	58	3.0k
Sachiko Akashi‐Takamura Japan	26	2.1k 1.3×	1.9k 1.6×	475 0.7×	383 0.7×	189 0.7×	43	3.7k
Francesca Zolezzi Singapore	29	2.1k 1.3×	1.3k 1.1×	637 1.0×	449 0.8×	670 2.5×	66	4.0k
Ehud Zigmond Israel	26	2.2k 1.3×	1.0k 0.9×	475 0.7×	620 1.1×	186 0.7×	41	3.7k

Countries citing papers authored by June‐Yong Lee

Since Specialization

Citations

This map shows the geographic impact of June‐Yong Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by June‐Yong Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites June‐Yong Lee more than expected).

Fields of papers citing papers by June‐Yong Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by June‐Yong Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by June‐Yong Lee. The network helps show where June‐Yong Lee may publish in the future.

Co-authorship network of co-authors of June‐Yong Lee

This figure shows the co-authorship network connecting the top 25 collaborators of June‐Yong Lee. A scholar is included among the top collaborators of June‐Yong Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with June‐Yong Lee. June‐Yong Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Miller, Robert F., Jubilee Brown, JW Kim, et al.. (2025). 69O Novel regimens for persistent/recurrent rare epithelial ovarian carcinomas (EOCs) selected according to biomarker status: ENGOT-GYN2/GOG-3051/BOUQUET phase II study results. ESMO Open. 10. 105199–105199.

Chan, John K., June‐Yong Lee, Mariana Scaranti, et al.. (2025). LBA45 ROSELLA (GOG3073, ENGOTov72, APGOT-OV10): Relacorilant + nab-paclitaxel in the subgroup of patients with platinum-resistant ovarian cancer (PROC) previously exposed to a PARP inhibitor. Annals of Oncology. 36. S1588–S1589.

Xiang, Yang, Hong Zhu, June‐Yong Lee, et al.. (2024). 23O A randomized, phase III, double-blind study of chemoradiotherapy with or without pembrolizumab in patients with high-risk, locally advanced, cervical cancer (KEYNOTE-A18/ENGOT-cx11/GOG-3047): Results for patients enrolled in Asia. ESMO Open. 9. 103523–103523.

Park, Ji‐Ho, Dasom Kim, June‐Yong Lee, et al.. (2024). ETV5 promotes lupus pathogenesis and follicular helper T cell differentiation by inducing osteopontin expression. Proceedings of the National Academy of Sciences. 121(24). e2322009121–e2322009121. 4 indexed citations

Kim, Suwon, Hana Lee, June‐Yong Lee, et al.. (2024). 5-aminosalicylic acid suppresses osteoarthritis through the OSCAR-PPARγ axis. Nature Communications. 15(1). 1024–1024. 16 indexed citations

Xiang, Yang, Kazuki Hasegawa, Giovanni Scambia, et al.. (2024). 709O Pembrolizumab plus chemoradiotherapy for high-risk locally advanced cervical cancer: Overall survival results from the randomized, double-blind, phase III ENGOT-cx11/GOG-3047/KEYNOTE-A18 study. Annals of Oncology. 35. S544–S544. 4 indexed citations

Lee, June‐Yong, et al.. (2023). IgSF11 deficiency alleviates osteoarthritis in mice by suppressing early subchondral bone changes. Experimental & Molecular Medicine. 55(12). 2576–2585. 3 indexed citations

Lee, June‐Yong, Jinwon Lee, Lin Wang, et al.. (2023). 744MO AdvanTIG-202: Phase II randomized, multicenter, open-label study of tislelizumab (TIS) with or without ociperlimab (OCI) in patients (pts) with previously treated recurrent/metastatic (R/M) cervical cancer (CC). Annals of Oncology. 34. S509–S510. 4 indexed citations

Friedman, Meyer J., et al.. (2023). Transcriptional and Epigenetic Regulation of Context-Dependent Plasticity in T-Helper Lineages. Immune Network. 23(1). e5–e5. 6 indexed citations

10.

Westin, Shannon N., Kathleen N. Moore, Hye Sook Chon, et al.. (2023). LBA41 Durvalumab (durva) plus carboplatin/paclitaxel (CP) followed by maintenance (mtx) durva ± olaparib (ola) as a first-line (1L) treatment for newly diagnosed advanced or recurrent endometrial cancer (EC): Results from the phase III DUO-E/GOG-3041/ENGOT-EN10 trial. Annals of Oncology. 34. S1282–S1283. 7 indexed citations

11.

Lee, June‐Yong, et al.. (2022). Context-Dependent Regulation of Type17 Immunity by Microbiota at the Intestinal Barrier. Immune Network. 22(6). e46–e46. 17 indexed citations

12.

Miraldi, Emily R., Maria Pokrovskii, Aaron Watters, et al.. (2019). Leveraging chromatin accessibility for transcriptional regulatory network inference in T Helper 17 Cells. Genome Research. 29(3). 449–463. 67 indexed citations

13.

Renkema, Kristin R., June‐Yong Lee, You Jeong Lee, et al.. (2016). IL-4 sensitivity shapes the peripheral CD8+ T cell pool and response to infection. The Journal of Experimental Medicine. 213(7). 1319–1329. 44 indexed citations

14.

Lee, June‐Yong, Cara Skon-Hegg, You Jeong Lee, et al.. (2015). The Transcription Factor KLF2 Restrains CD4 + T Follicular Helper Cell Differentiation. Immunity. 42(2). 252–264. 134 indexed citations

15.

Skon-Hegg, Cara, June‐Yong Lee, Kristin G. Anderson, et al.. (2013). Transcriptional downregulation of S1pr1 is required for the establishment of resident memory CD8+ T cells. Nature Immunology. 14(12). 1285–1293. 611 indexed citations breakdown →

16.

Yang, Chul‐Su, Mary A. Rodgers, Jong‐Soo Lee, et al.. (2012). The Autophagy Regulator Rubicon Is a Feedback Inhibitor of CARD9-Mediated Host Innate Immunity. Cell Host & Microbe. 11(3). 277–289. 82 indexed citations

17.

Zhao, Zhen, Soohwan Oh, Dapeng Li, et al.. (2012). A Dual Role for UVRAG in Maintaining Chromosomal Stability Independent of Autophagy. Developmental Cell. 22(5). 1001–1016. 79 indexed citations

18.

Yang, Chul‐Su, Jong‐Soo Lee, Mary A. Rodgers, et al.. (2012). Autophagy Protein Rubicon Mediates Phagocytic NADPH Oxidase Activation in Response to Microbial Infection or TLR Stimulation. Cell Host & Microbe. 11(3). 264–276. 125 indexed citations

19.

Kwok, Seung‐Ki, June‐Yong Lee, Se‐Ho Park, et al.. (2008). Dysfunctional interferon-α production by peripheral plasmacytoid dendritic cells upon Toll-like receptor-9 stimulation in patients with systemic lupus erythematosus. Arthritis Research & Therapy. 10(2). R29–R29. 57 indexed citations

20.

Lee, June‐Yong, Amanda Nicoll, P. Angus, Richard A. Smallwood, & SA Locarnini. (1999). Detection of duck hepatitis B virus replicative markers in primary cultures of bile duct epithelial cells. Hepatology. 30.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact